Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Reducing Nocturia in Males with Benign Prostatic Enlargement
TCTR20250907004Phase 3Recruiting
- Sponsor
- Phramongkutklao Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in benign prostatic hyperplasia (BPH), sponsored by Phramongkutklao Hospital. Started Oct 2025; status: recruiting.
02
Drugs
melatonin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on TCTR20250907004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250907004.